HRT Financial’s Unilever UL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-248,941
Closed -$16.3M 4768
2025
Q4
$16.3M Buy
248,941
+84,785
+52% +$5.7M 0.05% 285
2025
Q3
$10.9M Buy
+164,156
New +$11.3M 0.04% 367
2025
Q2
Sell
-192,000
Closed -$12.9M 3556
2025
Q1
$12.9M Sell
192,000
-20,425
-10% -$1.32M 0.08% 186
2024
Q4
$13.6M Buy
212,425
+91,375
+75% +$6.17M 0.07% 178
2024
Q3
$8.85M Buy
+121,050
New +$8.37M 0.04% 267
2024
Q2
Sell
-708,404
Closed -$40M 3142
2024
Q1
$40M Buy
708,404
+270,659
+62% +$15M 0.25% 35
2023
Q4
$23.9M Buy
437,745
+268,081
+158% +$14.5M 0.17% 54
2023
Q3
$9.43M Buy
169,664
+165,399
+3,878% +$9.56M 0.09% 145
2023
Q2
$250K Buy
+4,265
New +$253K ﹤0.01% 1735
2023
Q1
Sell
-4,596
Closed -$260K 3226
2022
Q4
$260K Sell
4,596
-50,660
-92% -$2.71M ﹤0.01% 1805
2022
Q3
$2.73M Buy
+55,256
New +$2.89M 0.03% 501
2016
Q3
Sell
-4,280
Closed -$230K 172
2016
Q2
$230K Buy
+4,280
New +$220K 0.14% 84

Other funds holding UL

HRT Financial's UL Position: Q1 2026 in Review

HRT Financial sold out of Unilever (UL) in Q1 2026, closing a stake of 248,941 shares — an estimated $16.3M sold.

HRT Financial first reported a position in UL in Q2 2016 and held it in 12 quarters. The position peaked at $40M in Q1 2024. 1,166 funds tracked by Wall St. Rank hold UL as of Q1 2026.

  • HRT Financial reported no remaining Unilever position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 248,941 Unilever shares in Q1 2026, an estimated $16.3M.
  • HRT Financial first reported a position in Unilever in Q2 2016 and held it in 12 quarters.
  • HRT Financial's Unilever position peaked at $40M in Q1 2024.
  • 1,166 funds tracked by Wall St. Rank held Unilever as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.